Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
109.11
Dollar change
-2.34
Percentage change
-2.10
%
IndexS&P 500 P/E33.41 EPS (ttm)3.27 Insider Own0.73% Shs Outstand1.73B Perf Week-1.88%
Market Cap189.33B Forward P/E21.21 EPS next Y5.14 Insider Trans-0.97% Shs Float1.72B Perf Month-9.20%
Income5.70B PEG4.28 EPS next Q0.95 Inst Own77.11% Short Float0.84% Perf Quarter-3.87%
Sales40.11B P/S4.72 EPS this Y4.03% Inst Trans0.27% Short Ratio2.53 Perf Half Y17.78%
Book/sh22.26 P/B4.90 EPS next Y11.38% ROA7.72% Short Interest14.48M Perf Year6.39%
Cash/sh4.19 P/C26.01 EPS next 5Y7.80% ROE15.15% 52W Range89.67 - 121.64 Perf YTD-0.87%
Dividend Est.2.12 (1.94%) P/FCF37.42 EPS past 5Y19.65% ROI10.73% 52W High-10.30% Beta0.74
Dividend TTM2.63 (2.41%) Quick Ratio1.16 Sales past 5Y6.10% Gross Margin49.97% 52W Low21.67% ATR (14)1.97
Dividend Ex-DateApr 12, 2024 Current Ratio1.64 EPS Y/Y TTM-16.61% Oper. Margin16.09% RSI (14)37.36 Volatility1.52% 1.71%
Employees114000 Debt/Eq0.41 Sales Y/Y TTM-8.12% Profit Margin14.22% Recom1.85 Target Price126.73
Option/ShortYes / Yes LT Debt/Eq0.38 EPS Q/Q54.85% Payout63.81% Rel Volume0.71 Prev Close111.45
Sales Surprise0.54% EPS Surprise0.03% Sales Q/Q1.49% EarningsApr 17 BMO Avg Volume5.72M Price109.11
SMA20-2.77% SMA50-4.96% SMA2002.27% Trades Volume4,041,363 Change-2.10%
Date Action Analyst Rating Change Price Target Change
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Apr-20-23Reiterated Raymond James Outperform $116 → $123
Apr-20-23Reiterated JP Morgan Overweight $118 → $122
Apr-20-23Reiterated Bernstein Outperform $132 → $133
Apr-20-23Reiterated Barclays Overweight $125 → $127
Mar-29-23Initiated UBS Buy $117
Oct-26-22Initiated Mizuho Neutral $105
Apr-12-24 09:51AM
09:15AM
08:00AM
Apr-11-24 07:02AM
06:15AM
05:50PM Loading…
Apr-09-24 05:50PM
Apr-08-24 01:50PM
10:10AM
09:00AM
Apr-05-24 09:52AM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:11PM
11:18AM
09:36AM
09:23AM Loading…
09:23AM
09:07AM
09:00AM
Apr-01-24 06:00PM
09:00AM
Mar-31-24 04:34PM
Mar-27-24 04:30PM
12:25PM
Mar-26-24 06:00PM
09:00AM
08:02AM
07:45AM
06:18AM
06:07AM
05:15AM
12:58PM Loading…
Mar-25-24 12:58PM
09:15AM
Mar-24-24 10:42AM
Mar-22-24 04:25AM
12:33AM
Mar-21-24 10:25AM
Mar-20-24 05:50PM
08:11AM
08:00AM
Mar-19-24 06:00PM
01:40PM
09:30AM
08:49AM
08:00AM
Mar-18-24 09:50AM
Mar-17-24 08:50AM
Mar-15-24 10:37PM
04:34PM
04:10PM
03:34PM
09:00AM
08:30AM
Mar-14-24 11:02AM
Mar-12-24 05:50PM
08:31AM
06:00AM
Mar-11-24 07:03PM
06:00PM
10:10AM
05:35AM
Mar-07-24 12:27PM
05:00AM
Mar-06-24 04:15PM
02:47PM
11:48AM
11:36AM
10:25AM
09:00AM
06:00AM
Mar-05-24 05:50PM
Mar-04-24 11:54PM
09:00AM
Mar-03-24 09:45AM
Feb-28-24 05:50PM
07:51AM
05:44AM
Feb-27-24 03:04PM
05:45AM
Feb-26-24 02:44PM
07:10AM
04:40AM
Feb-24-24 11:22AM
Feb-23-24 11:30AM
Feb-22-24 05:50PM
Feb-21-24 07:42PM
09:04AM
03:00AM
Feb-20-24 11:21AM
09:00AM
Feb-18-24 06:58AM
Feb-16-24 10:19AM
Feb-14-24 03:05PM
06:31AM
Feb-13-24 06:47PM
06:31PM
06:25PM
Feb-11-24 01:06PM
06:51AM
Feb-10-24 08:30AM
Feb-09-24 09:00AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50963114,116125,697Mar 04 07:18 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50853101,080184,806Mar 04 06:39 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5080194,91862,968Mar 04 07:14 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5069482,23984,314Mar 04 06:50 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5067680,10691,260Mar 04 07:09 PM
MCCOY JOHN A. JR.VICE PRESIDENTMar 01 '24Sale118.5047255,93218,760Mar 04 07:05 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Option Exercise59.9412,500749,25091,204Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Sale120.0012,5001,500,00078,704Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Option Exercise50.8042,5002,158,95090,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Sale112.5042,5004,781,25065,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Option Exercise44.4015,000666,00080,027Dec 18 05:36 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Sale108.0015,0001,620,00065,027Dec 18 05:36 PM
STARKS DANIEL JDirectorOct 26 '23Sale94.0550,0004,702,5266,725,316Oct 30 04:58 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08 '23Option Exercise38.405,000192,00075,427Aug 10 06:31 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08 '23Sale105.0310,4001,092,29765,027Aug 10 06:31 PM
STARKS DANIEL JDirectorJul 27 '23Sale113.7650,0005,688,1896,775,316Jul 28 05:10 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMay 02 '23Option Exercise47.008,226386,62278,653May 03 07:09 PM
STARKS DANIEL JDirectorMay 02 '23Sale111.0250,0005,551,1936,825,316May 02 08:04 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMay 02 '23Sale110.568,226909,47270,427May 03 07:09 PM